Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems
D Placha, J Jampilek - Pharmaceutics, 2021 - mdpi.com
Inflammatory diseases, whether caused by excessive stress on certain tissues/parts of the
body or arising from infections accompanying autoimmune or secondary diseases, have …
body or arising from infections accompanying autoimmune or secondary diseases, have …
[HTML][HTML] Genus Ziziphus for the treatment of chronic inflammatory diseases
A Alsayari, S Wahab - Saudi Journal of Biological Sciences, 2021 - Elsevier
Natural products and traditional medicine are rich sources for developing therapeutics for
chronic inflammatory diseases. However, the way from natural products/traditional …
chronic inflammatory diseases. However, the way from natural products/traditional …
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …
Клинические рекомендации по диагностике и лечению болезни Крона у взрослых (проект)
ВТ Ивашкин, ЮА Шелыгин, ДИ Абдулганиева… - …, 2020 - elibrary.ru
Этиология воспалительных заболеваний кишечника (ВЗК), в том числе БК, не
установлена: заболевание развивается в результате сочетания нескольких факторов …
установлена: заболевание развивается в результате сочетания нескольких факторов …
CT and MRI evaluations in Crohn's complications: a guide for the radiologist
Inflammatory bowel diseases (IBD) are a group of chronic inflammatory intestinal conditions
with unknown etiology. Crohn's disease (CD) and ulcerative colitis (UC) are the two main …
with unknown etiology. Crohn's disease (CD) and ulcerative colitis (UC) are the two main …
Strictures in Crohn's disease: from pathophysiology to treatment
M Crespi, P Dulbecco, A De Ceglie, M Conio - Digestive Diseases and …, 2020 - Springer
Despite recent advances aimed to treat transmural inflammation in Crohn's disease (CD)
patients, the progression to a structuring behavior still represents an issue for clinicians. As …
patients, the progression to a structuring behavior still represents an issue for clinicians. As …
Клинические рекомендации. Болезнь Крона (К50), взрослые
ЮА Шелыгин, ВТ Ивашкин, СИ Ачкасов… - …, 2023 - ruproctology.com
БК—болезнь Крона БОС—биологическая обратная связь ВЗК—воспалительные
заболевания кишечника ВТЭО—венозные тромбоэмболические осложнения гамма-ГТ …
заболевания кишечника ВТЭО—венозные тромбоэмболические осложнения гамма-ГТ …
Anti-leishmanial and anti-inflammatory agents from endophytes: a review
RMK Toghueo - Natural Products and Bioprospecting, 2019 - Springer
Leishmaniases and chronic inflammatory diseases are the cause of millions of deaths in the
world each year. The treatment of leishmaniasis is facing serious drawbacks particularly due …
world each year. The treatment of leishmaniasis is facing serious drawbacks particularly due …
Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach
Cyclooxygenase-2 (COX-2) is an enzyme involved in inflammation. The overexpression of
COX-2 causes chronic inflammation, which can be prevented by COX-2 inhibitors …
COX-2 causes chronic inflammation, which can be prevented by COX-2 inhibitors …